General MedicationsOPHTHALMICStandard
ZIRGAN
GANCICLOVIR
Standard Dose
0.15%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview ZIRGAN is listed in Drugs@FDA under application 022211 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient GANCICLOVIR Form and strength GEL;OPHTHALMIC - 0.15% Sponsor BAUSCH AND LOMB Submission history Latest submission status date: 2026-01-20 00:00:00.
Structured Monograph
Clinical summary
Approval overview ZIRGAN is listed in Drugs@FDA under application 022211 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient GANCICLOVIR Form and strength GEL;OPHTHALMIC - 0.15% Sponsor BAUSCH AND LOMB Submission history Latest submission status date: 2026-01-20 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.